D-0777-2021 Class II Terminated
FDA drug recall D-0777-2021 was initiated by Granules USA, Inc. on Aug 11, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Feb 16, 2023). Affected quantity: 11,450,000 tablets.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 8, 2021
- Initiation Date
- Aug 11, 2021
- Termination Date
- Feb 16, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,450,000 tablets
Product description
Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36
Reason for recall
CGMP Deviations
Distribution pattern
NY
Code information
7620060a
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0777-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026